nodes	percent_of_prediction	percent_of_DWPC	metapath
Dalfampridine—KCNA5—artery—atherosclerosis	0.0237	0.11	CbGeAlD
Dalfampridine—KCNA7—cardiovascular system—atherosclerosis	0.0201	0.093	CbGeAlD
Dalfampridine—KCNG3—cardiovascular system—atherosclerosis	0.0145	0.0672	CbGeAlD
Dalfampridine—KCNB1—cardiovascular system—atherosclerosis	0.0125	0.058	CbGeAlD
Dalfampridine—KCNA4—cardiovascular system—atherosclerosis	0.0118	0.0548	CbGeAlD
Dalfampridine—KCND1—cardiovascular system—atherosclerosis	0.0108	0.0499	CbGeAlD
Dalfampridine—KCNC1—cardiovascular system—atherosclerosis	0.0103	0.0479	CbGeAlD
Dalfampridine—KCNC4—adipose tissue—atherosclerosis	0.00949	0.044	CbGeAlD
Dalfampridine—KCNA5—connective tissue—atherosclerosis	0.00947	0.0439	CbGeAlD
Dalfampridine—Urinary tract infection—Rosuvastatin—atherosclerosis	0.00911	0.0143	CcSEcCtD
Dalfampridine—Nasopharyngitis—Ezetimibe—atherosclerosis	0.00904	0.0142	CcSEcCtD
Dalfampridine—KCNA5—cardiovascular system—atherosclerosis	0.00824	0.0382	CbGeAlD
Dalfampridine—KCNF1—adipose tissue—atherosclerosis	0.00812	0.0377	CbGeAlD
Dalfampridine—KCNS3—cardiovascular system—atherosclerosis	0.00807	0.0374	CbGeAlD
Dalfampridine—KCNQ3—cardiovascular system—atherosclerosis	0.00807	0.0374	CbGeAlD
Dalfampridine—Nasopharyngitis—Pravastatin—atherosclerosis	0.00779	0.0123	CcSEcCtD
Dalfampridine—Infestation—Ezetimibe—atherosclerosis	0.00779	0.0122	CcSEcCtD
Dalfampridine—Infestation NOS—Ezetimibe—atherosclerosis	0.00779	0.0122	CcSEcCtD
Dalfampridine—Urinary tract infection—Lovastatin—atherosclerosis	0.00772	0.0121	CcSEcCtD
Dalfampridine—Mental disorder—Rosuvastatin—atherosclerosis	0.00737	0.0116	CcSEcCtD
Dalfampridine—KCNS3—adipose tissue—atherosclerosis	0.00711	0.033	CbGeAlD
Dalfampridine—KCND2—cardiovascular system—atherosclerosis	0.00703	0.0326	CbGeAlD
Dalfampridine—Connective tissue disorder—Ezetimibe—atherosclerosis	0.00687	0.0108	CcSEcCtD
Dalfampridine—Angioedema—Rosuvastatin—atherosclerosis	0.00669	0.0105	CcSEcCtD
Dalfampridine—Urinary tract infection—Pravastatin—atherosclerosis	0.00653	0.0103	CcSEcCtD
Dalfampridine—Angiopathy—Ezetimibe—atherosclerosis	0.00634	0.00997	CcSEcCtD
Dalfampridine—Immune system disorder—Ezetimibe—atherosclerosis	0.00631	0.00993	CcSEcCtD
Dalfampridine—Mediastinal disorder—Ezetimibe—atherosclerosis	0.0063	0.00991	CcSEcCtD
Dalfampridine—KCND2—adipose tissue—atherosclerosis	0.0062	0.0287	CbGeAlD
Dalfampridine—KCND3—cardiovascular system—atherosclerosis	0.00613	0.0284	CbGeAlD
Dalfampridine—Mental disorder—Ezetimibe—atherosclerosis	0.00612	0.00963	CcSEcCtD
Dalfampridine—Confusional state—Rosuvastatin—atherosclerosis	0.00602	0.00948	CcSEcCtD
Dalfampridine—Back pain—Lovastatin—atherosclerosis	0.006	0.00944	CcSEcCtD
Dalfampridine—KCNQ1—cardiovascular system—atherosclerosis	0.00594	0.0275	CbGeAlD
Dalfampridine—Infection—Rosuvastatin—atherosclerosis	0.00594	0.00934	CcSEcCtD
Dalfampridine—Back pain—Ezetimibe—atherosclerosis	0.00589	0.00926	CcSEcCtD
Dalfampridine—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00586	0.00922	CcSEcCtD
Dalfampridine—Mental disorder—Simvastatin—atherosclerosis	0.00584	0.00919	CcSEcCtD
Dalfampridine—Tremor—Lovastatin—atherosclerosis	0.00581	0.00914	CcSEcCtD
Dalfampridine—Angioedema—Lovastatin—atherosclerosis	0.00567	0.00892	CcSEcCtD
Dalfampridine—Angioedema—Ezetimibe—atherosclerosis	0.00556	0.00875	CcSEcCtD
Dalfampridine—Angiopathy—Niacin—atherosclerosis	0.00555	0.00873	CcSEcCtD
Dalfampridine—Tremor—Simvastatin—atherosclerosis	0.00544	0.00855	CcSEcCtD
Dalfampridine—KCND3—adipose tissue—atherosclerosis	0.00541	0.0251	CbGeAlD
Dalfampridine—Insomnia—Rosuvastatin—atherosclerosis	0.0054	0.0085	CcSEcCtD
Dalfampridine—Paraesthesia—Rosuvastatin—atherosclerosis	0.00536	0.00844	CcSEcCtD
Dalfampridine—Angioedema—Simvastatin—atherosclerosis	0.0053	0.00834	CcSEcCtD
Dalfampridine—Chest pain—Lovastatin—atherosclerosis	0.00528	0.00831	CcSEcCtD
Dalfampridine—Anxiety—Lovastatin—atherosclerosis	0.00526	0.00828	CcSEcCtD
Dalfampridine—Dyspepsia—Rosuvastatin—atherosclerosis	0.00526	0.00827	CcSEcCtD
Dalfampridine—KCNQ1—adipose tissue—atherosclerosis	0.00523	0.0243	CbGeAlD
Dalfampridine—Chest pain—Ezetimibe—atherosclerosis	0.00518	0.00815	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00514	0.00809	CcSEcCtD
Dalfampridine—Constipation—Rosuvastatin—atherosclerosis	0.00511	0.00804	CcSEcCtD
Dalfampridine—Confusional state—Lovastatin—atherosclerosis	0.00511	0.00803	CcSEcCtD
Dalfampridine—Anaphylactic shock—Lovastatin—atherosclerosis	0.00506	0.00796	CcSEcCtD
Dalfampridine—Infection—Lovastatin—atherosclerosis	0.00503	0.00791	CcSEcCtD
Dalfampridine—Confusional state—Ezetimibe—atherosclerosis	0.00501	0.00788	CcSEcCtD
Dalfampridine—KCNS3—liver—atherosclerosis	0.00499	0.0231	CbGeAlD
Dalfampridine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00497	0.00781	CcSEcCtD
Dalfampridine—Chest pain—Simvastatin—atherosclerosis	0.00494	0.00777	CcSEcCtD
Dalfampridine—Infection—Ezetimibe—atherosclerosis	0.00493	0.00776	CcSEcCtD
Dalfampridine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00492	0.00774	CcSEcCtD
Dalfampridine—Anxiety—Simvastatin—atherosclerosis	0.00492	0.00774	CcSEcCtD
Dalfampridine—Tremor—Pravastatin—atherosclerosis	0.00492	0.00773	CcSEcCtD
Dalfampridine—Nervous system disorder—Ezetimibe—atherosclerosis	0.00487	0.00766	CcSEcCtD
Dalfampridine—Angioedema—Niacin—atherosclerosis	0.00487	0.00766	CcSEcCtD
Dalfampridine—Skin disorder—Ezetimibe—atherosclerosis	0.00482	0.00759	CcSEcCtD
Dalfampridine—Angioedema—Pravastatin—atherosclerosis	0.00479	0.00754	CcSEcCtD
Dalfampridine—Confusional state—Simvastatin—atherosclerosis	0.00478	0.00751	CcSEcCtD
Dalfampridine—Urticaria—Rosuvastatin—atherosclerosis	0.00475	0.00747	CcSEcCtD
Dalfampridine—Anaphylactic shock—Simvastatin—atherosclerosis	0.00474	0.00745	CcSEcCtD
Dalfampridine—Infection—Simvastatin—atherosclerosis	0.00471	0.0074	CcSEcCtD
Dalfampridine—Insomnia—Lovastatin—atherosclerosis	0.00458	0.0072	CcSEcCtD
Dalfampridine—Paraesthesia—Lovastatin—atherosclerosis	0.00455	0.00715	CcSEcCtD
Dalfampridine—Dyspnoea—Lovastatin—atherosclerosis	0.00451	0.0071	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00451	0.00709	CcSEcCtD
Dalfampridine—Insomnia—Ezetimibe—atherosclerosis	0.00449	0.00706	CcSEcCtD
Dalfampridine—Chest pain—Pravastatin—atherosclerosis	0.00447	0.00702	CcSEcCtD
Dalfampridine—Paraesthesia—Ezetimibe—atherosclerosis	0.00446	0.00701	CcSEcCtD
Dalfampridine—Dyspepsia—Lovastatin—atherosclerosis	0.00446	0.00701	CcSEcCtD
Dalfampridine—Anxiety—Pravastatin—atherosclerosis	0.00445	0.007	CcSEcCtD
Dalfampridine—Dyspnoea—Ezetimibe—atherosclerosis	0.00443	0.00696	CcSEcCtD
Dalfampridine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.0044	0.00692	CcSEcCtD
Dalfampridine—Dyspepsia—Ezetimibe—atherosclerosis	0.00437	0.00688	CcSEcCtD
Dalfampridine—Anaphylactic shock—Niacin—atherosclerosis	0.00435	0.00684	CcSEcCtD
Dalfampridine—Constipation—Lovastatin—atherosclerosis	0.00433	0.00681	CcSEcCtD
Dalfampridine—Confusional state—Pravastatin—atherosclerosis	0.00432	0.00679	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00429	0.00674	CcSEcCtD
Dalfampridine—Asthenia—Rosuvastatin—atherosclerosis	0.00429	0.00674	CcSEcCtD
Dalfampridine—Insomnia—Simvastatin—atherosclerosis	0.00428	0.00674	CcSEcCtD
Dalfampridine—Anaphylactic shock—Pravastatin—atherosclerosis	0.00428	0.00673	CcSEcCtD
Dalfampridine—Infection—Pravastatin—atherosclerosis	0.00425	0.00669	CcSEcCtD
Dalfampridine—Paraesthesia—Simvastatin—atherosclerosis	0.00425	0.00669	CcSEcCtD
Dalfampridine—Constipation—Ezetimibe—atherosclerosis	0.00425	0.00668	CcSEcCtD
Dalfampridine—Skin disorder—Niacin—atherosclerosis	0.00422	0.00664	CcSEcCtD
Dalfampridine—Dyspnoea—Simvastatin—atherosclerosis	0.00422	0.00664	CcSEcCtD
Dalfampridine—Feeling abnormal—Lovastatin—atherosclerosis	0.00417	0.00656	CcSEcCtD
Dalfampridine—Dyspepsia—Simvastatin—atherosclerosis	0.00417	0.00656	CcSEcCtD
Dalfampridine—Feeling abnormal—Ezetimibe—atherosclerosis	0.00409	0.00644	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00409	0.00643	CcSEcCtD
Dalfampridine—Hypotension—Niacin—atherosclerosis	0.00406	0.00639	CcSEcCtD
Dalfampridine—Constipation—Simvastatin—atherosclerosis	0.00405	0.00637	CcSEcCtD
Dalfampridine—Urticaria—Lovastatin—atherosclerosis	0.00402	0.00633	CcSEcCtD
Dalfampridine—Dizziness—Rosuvastatin—atherosclerosis	0.00395	0.00621	CcSEcCtD
Dalfampridine—Urticaria—Ezetimibe—atherosclerosis	0.00395	0.00621	CcSEcCtD
Dalfampridine—Insomnia—Niacin—atherosclerosis	0.00393	0.00619	CcSEcCtD
Dalfampridine—Paraesthesia—Niacin—atherosclerosis	0.0039	0.00614	CcSEcCtD
Dalfampridine—Feeling abnormal—Simvastatin—atherosclerosis	0.0039	0.00614	CcSEcCtD
Dalfampridine—Dyspnoea—Niacin—atherosclerosis	0.00388	0.0061	CcSEcCtD
Dalfampridine—Insomnia—Pravastatin—atherosclerosis	0.00387	0.00609	CcSEcCtD
Dalfampridine—Paraesthesia—Pravastatin—atherosclerosis	0.00384	0.00605	CcSEcCtD
Dalfampridine—Dyspepsia—Niacin—atherosclerosis	0.00383	0.00602	CcSEcCtD
Dalfampridine—Dyspnoea—Pravastatin—atherosclerosis	0.00382	0.006	CcSEcCtD
Dalfampridine—KCND3—liver—atherosclerosis	0.00379	0.0176	CbGeAlD
Dalfampridine—Dyspepsia—Pravastatin—atherosclerosis	0.00377	0.00593	CcSEcCtD
Dalfampridine—Rash—Rosuvastatin—atherosclerosis	0.00377	0.00592	CcSEcCtD
Dalfampridine—Dermatitis—Rosuvastatin—atherosclerosis	0.00376	0.00592	CcSEcCtD
Dalfampridine—Urticaria—Simvastatin—atherosclerosis	0.00376	0.00592	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Niacin—atherosclerosis	0.00375	0.0059	CcSEcCtD
Dalfampridine—Headache—Rosuvastatin—atherosclerosis	0.00374	0.00589	CcSEcCtD
Dalfampridine—Hypersensitivity—Lovastatin—atherosclerosis	0.00373	0.00587	CcSEcCtD
Dalfampridine—KCNQ1—liver—atherosclerosis	0.00367	0.017	CbGeAlD
Dalfampridine—Constipation—Pravastatin—atherosclerosis	0.00366	0.00576	CcSEcCtD
Dalfampridine—Hypersensitivity—Ezetimibe—atherosclerosis	0.00366	0.00575	CcSEcCtD
Dalfampridine—Asthenia—Lovastatin—atherosclerosis	0.00363	0.00571	CcSEcCtD
Dalfampridine—Asthenia—Ezetimibe—atherosclerosis	0.00356	0.0056	CcSEcCtD
Dalfampridine—Nausea—Rosuvastatin—atherosclerosis	0.00355	0.00558	CcSEcCtD
Dalfampridine—Feeling abnormal—Pravastatin—atherosclerosis	0.00353	0.00555	CcSEcCtD
Dalfampridine—Hypersensitivity—Simvastatin—atherosclerosis	0.00349	0.00549	CcSEcCtD
Dalfampridine—Urticaria—Niacin—atherosclerosis	0.00345	0.00543	CcSEcCtD
Dalfampridine—Urticaria—Pravastatin—atherosclerosis	0.0034	0.00535	CcSEcCtD
Dalfampridine—Asthenia—Simvastatin—atherosclerosis	0.0034	0.00534	CcSEcCtD
Dalfampridine—Dizziness—Lovastatin—atherosclerosis	0.00335	0.00527	CcSEcCtD
Dalfampridine—Dizziness—Ezetimibe—atherosclerosis	0.00328	0.00517	CcSEcCtD
Dalfampridine—Vomiting—Lovastatin—atherosclerosis	0.00322	0.00506	CcSEcCtD
Dalfampridine—Hypersensitivity—Niacin—atherosclerosis	0.0032	0.00504	CcSEcCtD
Dalfampridine—Rash—Lovastatin—atherosclerosis	0.00319	0.00502	CcSEcCtD
Dalfampridine—Dermatitis—Lovastatin—atherosclerosis	0.00319	0.00502	CcSEcCtD
Dalfampridine—Headache—Lovastatin—atherosclerosis	0.00317	0.00499	CcSEcCtD
Dalfampridine—Vomiting—Ezetimibe—atherosclerosis	0.00316	0.00497	CcSEcCtD
Dalfampridine—Hypersensitivity—Pravastatin—atherosclerosis	0.00315	0.00496	CcSEcCtD
Dalfampridine—Dizziness—Simvastatin—atherosclerosis	0.00313	0.00493	CcSEcCtD
Dalfampridine—Rash—Ezetimibe—atherosclerosis	0.00313	0.00492	CcSEcCtD
Dalfampridine—Dermatitis—Ezetimibe—atherosclerosis	0.00313	0.00492	CcSEcCtD
Dalfampridine—Asthenia—Niacin—atherosclerosis	0.00312	0.00491	CcSEcCtD
Dalfampridine—Headache—Ezetimibe—atherosclerosis	0.00311	0.00489	CcSEcCtD
Dalfampridine—Asthenia—Pravastatin—atherosclerosis	0.00307	0.00483	CcSEcCtD
Dalfampridine—Vomiting—Simvastatin—atherosclerosis	0.00301	0.00474	CcSEcCtD
Dalfampridine—Nausea—Lovastatin—atherosclerosis	0.00301	0.00473	CcSEcCtD
Dalfampridine—Rash—Simvastatin—atherosclerosis	0.00299	0.0047	CcSEcCtD
Dalfampridine—Dermatitis—Simvastatin—atherosclerosis	0.00298	0.00469	CcSEcCtD
Dalfampridine—Headache—Simvastatin—atherosclerosis	0.00297	0.00467	CcSEcCtD
Dalfampridine—Nausea—Ezetimibe—atherosclerosis	0.00295	0.00464	CcSEcCtD
Dalfampridine—Dizziness—Niacin—atherosclerosis	0.00288	0.00452	CcSEcCtD
Dalfampridine—Dizziness—Pravastatin—atherosclerosis	0.00283	0.00445	CcSEcCtD
Dalfampridine—Nausea—Simvastatin—atherosclerosis	0.00281	0.00442	CcSEcCtD
Dalfampridine—Vomiting—Niacin—atherosclerosis	0.00276	0.00435	CcSEcCtD
Dalfampridine—Rash—Niacin—atherosclerosis	0.00274	0.00431	CcSEcCtD
Dalfampridine—Dermatitis—Niacin—atherosclerosis	0.00274	0.00431	CcSEcCtD
Dalfampridine—Headache—Niacin—atherosclerosis	0.00272	0.00428	CcSEcCtD
Dalfampridine—Vomiting—Pravastatin—atherosclerosis	0.00272	0.00428	CcSEcCtD
Dalfampridine—Rash—Pravastatin—atherosclerosis	0.0027	0.00425	CcSEcCtD
Dalfampridine—Dermatitis—Pravastatin—atherosclerosis	0.0027	0.00424	CcSEcCtD
Dalfampridine—Headache—Pravastatin—atherosclerosis	0.00268	0.00422	CcSEcCtD
Dalfampridine—Nausea—Niacin—atherosclerosis	0.00258	0.00406	CcSEcCtD
Dalfampridine—Nausea—Pravastatin—atherosclerosis	0.00254	0.004	CcSEcCtD
Dalfampridine—KCNH2—cardiovascular system—atherosclerosis	0.00226	0.0105	CbGeAlD
Dalfampridine—CYP2E1—cardiovascular system—atherosclerosis	0.00174	0.00808	CbGeAlD
Dalfampridine—CYP2E1—liver—atherosclerosis	0.00108	0.005	CbGeAlD
Dalfampridine—KCNS3—Metabolism—APOA2—atherosclerosis	0.000314	0.00212	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PLA2G2A—atherosclerosis	0.000314	0.00212	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—APOA2—atherosclerosis	0.000314	0.00212	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—APOA2—atherosclerosis	0.000314	0.00212	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PLA2G2A—atherosclerosis	0.000314	0.00212	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ABCG5—atherosclerosis	0.00031	0.00209	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ABCG5—atherosclerosis	0.00031	0.00209	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ABCG5—atherosclerosis	0.00031	0.00209	CbGpPWpGaD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—TNF—atherosclerosis	0.000309	0.00208	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—CYP7A1—atherosclerosis	0.000305	0.00205	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—CYP7A1—atherosclerosis	0.0003	0.00202	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—IL10—atherosclerosis	0.0003	0.00202	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—LPA—atherosclerosis	0.0003	0.00202	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—LPA—atherosclerosis	0.0003	0.00202	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—LPA—atherosclerosis	0.0003	0.00202	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ALOX5AP—atherosclerosis	0.000298	0.00201	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—APOA2—atherosclerosis	0.000298	0.00201	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PLA2G2A—atherosclerosis	0.000298	0.00201	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ALOX15—atherosclerosis	0.000298	0.00201	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ABCG5—atherosclerosis	0.000294	0.00198	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—BGN—atherosclerosis	0.00029	0.00196	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—BGN—atherosclerosis	0.00029	0.00196	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—BGN—atherosclerosis	0.00029	0.00196	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—APOA5—atherosclerosis	0.000287	0.00194	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—APOA5—atherosclerosis	0.000287	0.00194	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—APOA5—atherosclerosis	0.000287	0.00194	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—LPA—atherosclerosis	0.000284	0.00191	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—CYP27A1—atherosclerosis	0.000282	0.0019	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—MAPK8—atherosclerosis	0.000279	0.00188	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—CYP27A1—atherosclerosis	0.000278	0.00187	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PLA2G1B—atherosclerosis	0.000277	0.00186	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PLA2G1B—atherosclerosis	0.000277	0.00186	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PLA2G1B—atherosclerosis	0.000277	0.00186	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—BGN—atherosclerosis	0.000275	0.00185	CbGpPWpGaD
Dalfampridine—KCNH2—Hematopoietic Stem Cell Differentiation—IL6—atherosclerosis	0.000274	0.00185	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—APOA5—atherosclerosis	0.000272	0.00183	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ALOX5—atherosclerosis	0.000267	0.0018	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ALOX5—atherosclerosis	0.000267	0.0018	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ALOX5—atherosclerosis	0.000267	0.0018	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PLA2G1B—atherosclerosis	0.000262	0.00177	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ALOX5—atherosclerosis	0.000253	0.00171	CbGpPWpGaD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—IL6—atherosclerosis	0.000249	0.00168	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—NAMPT—atherosclerosis	0.00024	0.00161	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—NAMPT—atherosclerosis	0.00024	0.00161	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—NAMPT—atherosclerosis	0.00024	0.00161	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—LIPC—atherosclerosis	0.000238	0.0016	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—LIPC—atherosclerosis	0.000238	0.0016	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—LIPC—atherosclerosis	0.000238	0.0016	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—APOC3—atherosclerosis	0.000237	0.00159	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—APOC3—atherosclerosis	0.000237	0.00159	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—APOC3—atherosclerosis	0.000237	0.00159	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—LPL—atherosclerosis	0.000235	0.00159	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—LPL—atherosclerosis	0.000235	0.00159	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—LDLR—atherosclerosis	0.000235	0.00158	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—LDLR—atherosclerosis	0.000235	0.00158	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—LDLR—atherosclerosis	0.000235	0.00158	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CETP—atherosclerosis	0.00023	0.00155	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CETP—atherosclerosis	0.00023	0.00155	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CETP—atherosclerosis	0.00023	0.00155	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—NAMPT—atherosclerosis	0.000227	0.00153	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—LIPC—atherosclerosis	0.000226	0.00152	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—APOC3—atherosclerosis	0.000224	0.00151	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—CD36—atherosclerosis	0.000224	0.00151	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—CD36—atherosclerosis	0.000224	0.00151	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—LDLR—atherosclerosis	0.000223	0.0015	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MMP2—atherosclerosis	0.000221	0.00149	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—MMP2—atherosclerosis	0.000221	0.00149	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—SCARB1—atherosclerosis	0.00022	0.00148	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—SCARB1—atherosclerosis	0.00022	0.00148	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—SCARB1—atherosclerosis	0.00022	0.00148	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CETP—atherosclerosis	0.000218	0.00147	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—SCARB1—atherosclerosis	0.000209	0.0014	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—PPARA—atherosclerosis	0.000208	0.0014	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—PPARA—atherosclerosis	0.000208	0.0014	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—HMGCR—atherosclerosis	0.000208	0.0014	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—HMGCR—atherosclerosis	0.000208	0.0014	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—HMGCR—atherosclerosis	0.000208	0.0014	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—IL6—atherosclerosis	0.000203	0.00137	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—LEP—atherosclerosis	0.000197	0.00133	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—LEP—atherosclerosis	0.000197	0.00133	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—HMGCR—atherosclerosis	0.000197	0.00133	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ABCA1—atherosclerosis	0.000185	0.00125	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ABCA1—atherosclerosis	0.000185	0.00125	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ABCA1—atherosclerosis	0.000185	0.00125	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—PRKCG—atherosclerosis	0.00018	0.00121	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—IL6—atherosclerosis	0.000178	0.0012	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ABCA1—atherosclerosis	0.000176	0.00118	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—PPARG—atherosclerosis	0.000172	0.00116	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—PPARG—atherosclerosis	0.000172	0.00116	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—INS—atherosclerosis	0.000169	0.00114	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—INS—atherosclerosis	0.000169	0.00114	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MMP9—atherosclerosis	0.000166	0.00112	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—MMP9—atherosclerosis	0.000166	0.00112	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—CXCL8—atherosclerosis	0.000164	0.00111	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—HMOX1—atherosclerosis	0.000159	0.00107	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—HMOX1—atherosclerosis	0.000159	0.00107	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—HMOX1—atherosclerosis	0.000159	0.00107	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MMP2—atherosclerosis	0.000158	0.00106	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MMP2—atherosclerosis	0.000158	0.00106	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—IL1B—atherosclerosis	0.000158	0.00106	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—APOB—atherosclerosis	0.000152	0.00102	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—APOB—atherosclerosis	0.000152	0.00102	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—APOB—atherosclerosis	0.000152	0.00102	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—HMOX1—atherosclerosis	0.000151	0.00101	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—VEGFA—atherosclerosis	0.000149	0.00101	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—VEGFA—atherosclerosis	0.000149	0.00101	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GSTM1—atherosclerosis	0.000148	0.000997	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GSTM1—atherosclerosis	0.000148	0.000997	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GSTM1—atherosclerosis	0.000148	0.000997	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—NFKB1—atherosclerosis	0.000147	0.00099	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—LPL—atherosclerosis	0.000145	0.000979	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—LPL—atherosclerosis	0.000145	0.000979	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—LPL—atherosclerosis	0.000145	0.000979	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—APOB—atherosclerosis	0.000144	0.000972	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GPX1—atherosclerosis	0.000142	0.000955	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GPX1—atherosclerosis	0.000142	0.000955	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GPX1—atherosclerosis	0.000142	0.000955	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MAPK3—atherosclerosis	0.000141	0.000951	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—MAPK3—atherosclerosis	0.000141	0.000951	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GSTM1—atherosclerosis	0.00014	0.000945	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CD36—atherosclerosis	0.000138	0.00093	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CD36—atherosclerosis	0.000138	0.00093	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CD36—atherosclerosis	0.000138	0.00093	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—LPL—atherosclerosis	0.000138	0.000928	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GPX1—atherosclerosis	0.000134	0.000905	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—VEGFA—atherosclerosis	0.000133	0.000898	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CD36—atherosclerosis	0.000131	0.000881	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—MTHFR—atherosclerosis	0.000131	0.000881	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—MTHFR—atherosclerosis	0.000131	0.000881	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—MTHFR—atherosclerosis	0.000131	0.000881	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PPARA—atherosclerosis	0.000128	0.000864	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PPARA—atherosclerosis	0.000128	0.000864	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PPARA—atherosclerosis	0.000128	0.000864	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—GSTM1—atherosclerosis	0.000126	0.000847	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—AGT—atherosclerosis	0.000124	0.000837	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—AGT—atherosclerosis	0.000124	0.000837	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—AGT—atherosclerosis	0.000124	0.000837	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—GSTM1—atherosclerosis	0.000124	0.000835	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—MTHFR—atherosclerosis	0.000124	0.000835	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—APOE—atherosclerosis	0.000122	0.00082	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—APOE—atherosclerosis	0.000122	0.00082	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—APOE—atherosclerosis	0.000122	0.00082	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PPARA—atherosclerosis	0.000122	0.000819	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CAV1—atherosclerosis	0.000121	0.000813	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CAV1—atherosclerosis	0.000121	0.000813	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CAV1—atherosclerosis	0.000121	0.000813	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—APOA1—atherosclerosis	0.00012	0.000811	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—APOA1—atherosclerosis	0.00012	0.000811	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—APOA1—atherosclerosis	0.00012	0.000811	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MMP9—atherosclerosis	0.000119	0.000799	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MMP9—atherosclerosis	0.000119	0.000799	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—AGT—atherosclerosis	0.000118	0.000794	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—NFKB1—atherosclerosis	0.000117	0.00079	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—NFKB1—atherosclerosis	0.000117	0.00079	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—APOE—atherosclerosis	0.000115	0.000778	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CAV1—atherosclerosis	0.000114	0.00077	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—TNF—atherosclerosis	0.000114	0.00077	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—APOA1—atherosclerosis	0.000114	0.000769	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3CG—atherosclerosis	0.00011	0.00074	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3CG—atherosclerosis	0.00011	0.00074	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3CG—atherosclerosis	0.00011	0.00074	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—VEGFA—atherosclerosis	0.000107	0.000717	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—VEGFA—atherosclerosis	0.000107	0.000717	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PPARG—atherosclerosis	0.000106	0.000715	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PPARG—atherosclerosis	0.000106	0.000715	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PPARG—atherosclerosis	0.000106	0.000715	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—STAT3—atherosclerosis	0.000105	0.00071	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—STAT3—atherosclerosis	0.000105	0.00071	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3CG—atherosclerosis	0.000104	0.000702	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—INS—atherosclerosis	0.000104	0.000701	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—INS—atherosclerosis	0.000104	0.000701	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—INS—atherosclerosis	0.000104	0.000701	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—IL6—atherosclerosis	0.000103	0.000695	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—IL6—atherosclerosis	0.000103	0.000695	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MAPK3—atherosclerosis	0.000101	0.000679	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MAPK3—atherosclerosis	0.000101	0.000679	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PPARG—atherosclerosis	0.000101	0.000677	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—INS—atherosclerosis	9.86e-05	0.000664	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—TGFB1—atherosclerosis	9.78e-05	0.000658	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—TGFB1—atherosclerosis	9.78e-05	0.000658	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ALB—atherosclerosis	9.54e-05	0.000642	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ALB—atherosclerosis	9.54e-05	0.000642	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ALB—atherosclerosis	9.54e-05	0.000642	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—IL6—atherosclerosis	9.22e-05	0.000621	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—TNF—atherosclerosis	9.13e-05	0.000615	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—TNF—atherosclerosis	9.13e-05	0.000615	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—NOS3—atherosclerosis	9.12e-05	0.000615	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—NOS3—atherosclerosis	9.12e-05	0.000615	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—NOS3—atherosclerosis	9.12e-05	0.000615	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ALB—atherosclerosis	9.04e-05	0.000609	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—LDLRAP1—atherosclerosis	8.92e-05	0.000601	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—NOS3—atherosclerosis	8.65e-05	0.000583	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PLTP—atherosclerosis	8.38e-05	0.000565	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PTGS2—atherosclerosis	8.35e-05	0.000562	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PTGS2—atherosclerosis	8.35e-05	0.000562	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PTGS2—atherosclerosis	8.35e-05	0.000562	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PTGS2—atherosclerosis	7.91e-05	0.000533	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—IL6—atherosclerosis	7.37e-05	0.000496	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—IL6—atherosclerosis	7.37e-05	0.000496	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ABCG8—atherosclerosis	7.27e-05	0.00049	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—LTA4H—atherosclerosis	7.27e-05	0.00049	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—AKT1—atherosclerosis	6.8e-05	0.000458	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—AKT1—atherosclerosis	6.8e-05	0.000458	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ABCG1—atherosclerosis	5.75e-05	0.000387	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—LCAT—atherosclerosis	5.4e-05	0.000364	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—FABP4—atherosclerosis	5.4e-05	0.000364	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—APOA4—atherosclerosis	5.3e-05	0.000357	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP7A1—atherosclerosis	5.21e-05	0.000351	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP27A1—atherosclerosis	4.82e-05	0.000324	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ALOX5AP—atherosclerosis	4.56e-05	0.000307	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ALOX15—atherosclerosis	4.56e-05	0.000307	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PLA2G2A—atherosclerosis	4.56e-05	0.000307	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—APOA2—atherosclerosis	4.56e-05	0.000307	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ABCG5—atherosclerosis	4.51e-05	0.000304	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—LPA—atherosclerosis	4.35e-05	0.000293	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—BGN—atherosclerosis	4.22e-05	0.000284	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—AKT1—atherosclerosis	4.19e-05	0.000282	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—AKT1—atherosclerosis	4.19e-05	0.000282	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—AKT1—atherosclerosis	4.19e-05	0.000282	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—APOA5—atherosclerosis	4.17e-05	0.000281	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PLA2G1B—atherosclerosis	4.02e-05	0.000271	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—AKT1—atherosclerosis	3.98e-05	0.000268	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ALOX5—atherosclerosis	3.88e-05	0.000261	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NAMPT—atherosclerosis	3.48e-05	0.000234	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—LIPC—atherosclerosis	3.46e-05	0.000233	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—APOC3—atherosclerosis	3.44e-05	0.000232	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—LDLR—atherosclerosis	3.42e-05	0.00023	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CETP—atherosclerosis	3.34e-05	0.000225	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SCARB1—atherosclerosis	3.2e-05	0.000215	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HMGCR—atherosclerosis	3.02e-05	0.000203	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ABCA1—atherosclerosis	2.69e-05	0.000181	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HMOX1—atherosclerosis	2.31e-05	0.000155	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—APOB—atherosclerosis	2.21e-05	0.000149	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTM1—atherosclerosis	2.15e-05	0.000145	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—LPL—atherosclerosis	2.11e-05	0.000142	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GPX1—atherosclerosis	2.06e-05	0.000139	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CD36—atherosclerosis	2.01e-05	0.000135	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—MTHFR—atherosclerosis	1.9e-05	0.000128	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PPARA—atherosclerosis	1.86e-05	0.000126	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—AGT—atherosclerosis	1.81e-05	0.000122	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—APOE—atherosclerosis	1.77e-05	0.000119	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CAV1—atherosclerosis	1.75e-05	0.000118	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—APOA1—atherosclerosis	1.75e-05	0.000118	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3CG—atherosclerosis	1.6e-05	0.000108	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PPARG—atherosclerosis	1.54e-05	0.000104	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—INS—atherosclerosis	1.51e-05	0.000102	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ALB—atherosclerosis	1.39e-05	9.33e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NOS3—atherosclerosis	1.33e-05	8.93e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PTGS2—atherosclerosis	1.21e-05	8.17e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—AKT1—atherosclerosis	6.09e-06	4.1e-05	CbGpPWpGaD
